Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis

References

• Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–7943. doi:10.3748/wjg.v21.i26.793326185366
   PubMed Web of Science ®Google Scholar
• Alsop BR, Sharma P. Esophageal Cancer. Gastroenterol Clin North Am. 2016;45(3):399–412. doi:10.1016/j.gtc.2016.04.00127546839
   PubMed Web of Science ®Google Scholar
• Codipilly DC, Qin Y, Dawsey SM, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018;88(3):413–426. doi:10.1016/j.gie.2018.04.235229709526
   PubMed Web of Science ®Google Scholar
• Ohashi S, Miyamoto S, Kikuchi O, et al. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149(7):1700–1715. doi:10.1053/j.gastro.2015.08.05426376349
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• Soria-Valles C, López-Soto A, Osorio FG, et al. Immune and inflammatory responses to DNA damage in cancer and aging. Mech Ageing Dev. 2017;165(Pt A):10–16. doi:10.1016/j.mad.2016.10.00427720808
   PubMedGoogle Scholar
• Bail J, Meneses K, Demark-Wahnefried W. Nutritional status and diet in cancer prevention. Semin Oncol Nurs. 2016;32(3):206–214. doi:10.1016/j.soncn.2016.05.00427539277
   PubMed Web of Science ®Google Scholar
• Toles M, Demark-Wahnefried W. Nutrition and the cancer survivor: evidence to guide oncology nursing practice. Semin Oncol Nurs. 2008;24(3):171–179. doi:10.1016/j.soncn.2008.05.00518687263
   PubMedGoogle Scholar
• Zhang Y, Wang L, Lin S, et al. Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis. Cancer Manag Res. 2018;10:4695–4708. doi:10.2147/CMAR.S17827130410403
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X. Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis. Cancer Manag Res. 2018;10:3023–3032. doi:10.2147/CMAR.S17409530214297
   PubMed Web of Science ®Google Scholar
• Li YJ, Yang X, Zhang WB, et al. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma. Cancer Manag Res. 2017;9:443–451. doi:10.2147/CMAR.S14682729033609
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-044225271081
   PubMed Web of Science ®Google Scholar
• Chen L, Yan Y, Zhu L, et al. Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. Cancer Manag Res. 2017;9:849–867. doi:10.2147/CMAR.S15102629276407
   PubMed Web of Science ®Google Scholar
• Geng Y, Shao Y, Zhu D, et al. Systemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci Rep. 2016;6:39482. doi:10.1038/srep3948228000729
   PubMed Web of Science ®Google Scholar
• Deng TB, Zhang J, Zhou YZ, et al. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer. Medicine (Baltimore). 2018;97(50):e13505. doi:10.1097/MD.000000000001350530558004
   PubMed Web of Science ®Google Scholar
• Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore). 2017;96(4):e5886. doi:10.1097/MD.000000000000588628121932
   PubMed Web of Science ®Google Scholar
• Shimizu T, Ishizuka M, Suzuki T, et al. The value of the C-reactive protein-to-albumin ratio is useful for predicting survival of patients with child-pugh class A undergoing liver resection for hepatocellular carcinoma. World J Surg. 2018;42(7):2218–2226. doi:10.1007/s00268-017-4446-029288307
   PubMed Web of Science ®Google Scholar
• Perisanidis C, Psyrri A, Cohen EE, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):960–970. doi:10.1016/j.ctrv.2015.10.00226604093
   PubMed Web of Science ®Google Scholar
• Wang L, Wang C, Wang J, et al. A novel systemic immune-inflammation index predicts survival and quality of life of patients aftercurative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143(10):2077–2086. doi:10.1007/s00432-017-2451-128601935
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Tsujimoto H, Hiraki S, et al. Prognostic value of preoperative systemic immunoinflammatory measures in patients with esophageal cancer. Ann Surg Oncol. 2018;25(11):3288–3299. doi:10.1245/s10434-018-6651-y30019304
   PubMed Web of Science ®Google Scholar
• Zhang H, Shang X, Ren P, et al. The predictive value of a preoperative systemic immune‐inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol. 2018. doi:10.1002/jcp.27052 [ [Epub ahead of print]].
   Web of Science ®Google Scholar
• Wei XL, Wang FH, Zhang DS, et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer. 2015;15:350. doi:10.1186/s12885-015-1584-325934640
   PubMed Web of Science ®Google Scholar
• Xu XL, Yu HQ, Hu W, et al. A novel inflammation-based prognostic score, the C-Reactive Protein/Albumin Ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10(9):e0138657. doi:10.1371/journal.pone.013865726390126
   PubMed Web of Science ®Google Scholar
• Otowa Y, Nakamura T, Yamamoto M, et al. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer. Dis Esophagus. 2017;30(12):1–5. doi:10.1093/dote/dox107
   PubMed Web of Science ®Google Scholar
• Jomrich G, Paireder M, Gleiss A, et al. Comparison of inflammation-based prognostic scores in a cohort of patients with resectable esophageal cancer. Gastroenterol Res Pract. 2017;2017:1678584. doi:10.1155/2017/167858428740506
   PubMed Web of Science ®Google Scholar
• Kunizaki M, Tominaga T, Wakata K, et al. Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Mol Clin Oncol. 2018;8(2):370–374. doi:10.3892/mco.2017.152729435305
   PubMed Web of Science ®Google Scholar
• Yu X, Wen Y, Lin Y, et al. The value of preoperative glasgow prognostic score and the C-Reactive protein to albumin ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer. 2018;9(5):807–815. doi:10.7150/jca.2275529581759
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhang J, Cai Y, et al. Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer. Medicine (Baltimore). 2018;97(38):e11435. doi:10.1097/MD.000000000001143530235653
   PubMed Web of Science ®Google Scholar
• Ji R, Ren Q, Bai S, et al. Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis. Medicine (Baltimore). 2018;97(25):e10824. doi:10.1097/MD.000000000001082429923974
   PubMed Web of Science ®Google Scholar
• Chen Z, Shao Y, Wang K, et al. Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis. Onco Targets Ther. 2016;9:6701–6710. doi:10.2147/OTT.S10846927822073
   PubMed Web of Science ®Google Scholar
• Bozkaya Y, Erdem GU, Demirci NS, et al. Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients. Curr Med Res Opin. 2018;35(2):1–8.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou X, He Y, et al. Prognostic role of platelet to lymphocyte ratio in prostate cancer: A meta-analysis. Medicine (Baltimore). 2018;97(40):e12504. doi:10.1097/MD.000000000001250430290605
   PubMed Web of Science ®Google Scholar
• Wang W, Liu W, Zhang N, et al. Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy. Oncol Lett. 2018;16(4):4879–4888. doi:10.3892/ol.2018.928530250554
   PubMed Web of Science ®Google Scholar
• Solmaz Medeni S, Acar C, Olgun A, et al. Can neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and platelet-to-lymphocyte ratio at day +100 be used as a prognostic marker in multiple myeloma patients with autologous transplantation?. Clin Transplant. 2018;32(9):e13359. doi:10.1111/ctr.1335930053318
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhao X, Lu J, et al. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies. Arch GynecolObstet. 2018;297(4):849–857. doi:10.1007/s00404-018-4678-8
   Google Scholar
• Huang L, Liu S, Lei Y, et al. Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget. 2016;7(28):44185–44193. doi:10.18632/oncotarget.992327283904
   PubMedGoogle Scholar
• Wang K, Diao F, Ye Z, et al. Prognostic value of systemic immune- inflammation index in patients with gastric cancer.Chin J Cancer. 2017;36(1):75. doi:10.1186/s40880-017-0243-228899420
   PubMedGoogle Scholar
• Liu X, Sun X, Liu J, et al. Preoperative C-Reactive Protein/Albumin Ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339–345. doi:10.1016/j.tranon.2015.06.00626310380
   PubMed Web of Science ®Google Scholar
• Toyokawa T, Muguruma K, Tamura T, et al. Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer. Oncotarget. 2018;9(50):29351–29364. doi:10.18632/oncotarget.2548630034622
   PubMedGoogle Scholar
• Mao M, Wei X, Sheng H, et al. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol Lett. 2017;14(6):7417–7424. doi:10.3892/ol.2017.717929344182
   PubMed Web of Science ®Google Scholar
• Saito H, Kono Y, Murakami Y, et al. Prognostic significance ofthe preoperative ratio of C-Reactive protein to Albumin andneutrophil-lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819–1825. doi:10.1007/s00268-017-4400-129270656
   PubMed Web of Science ®Google Scholar
• Sun F, Ge X, Liu Z, et al. Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer. World J Surg Oncol. 2017;15(1):191. doi:10.1186/s12957-017-1258-529065877
   PubMedGoogle Scholar